bioMérieux Webinar on Endotoxin Testing

30 October, 2018

bioMérieux WEBINAR
Endotoxin Testing Using Recombinant Horseshoe Crab Factor (rFC) - guest speaker Jay bolden, Eli Lilly

Tuesday 30 october, 2018, 4:00 - 5:15 pM CET (central european time)

Are you interested to understand the use, applications and approval process of sustainable rFC tests for endotoxin? 

Then join us for this complimentary webinar addressing the benefits advanced rFC assays offer, including consistency of results and increased lab efficiency.

As the number of companies validating rFC continues to grow, the second part of the webinar will cover the implementation through one of the leading rFC users. Eli Lilly recently received U.S. FDA approval for Emgality™ (galcanezumab-gnlm) using rFC as release test for bacterial endotoxin. The rFC test replaces the Limulus amebocyte lysate (LAL), thereby eliminating the use of a reagent extracted from live animals.

A Q&A session will follow after the presentations; use this unique opportunity to ask questions and discuss endotoxin testing of the 21st century.

Find out more at: 


Pioneering diagnostics